Clinical features of cerebral cavernous malformations patients with KRIT1 mutations

被引:80
作者
Denier, C
Labauge, P
Brunereau, L
Cavé-Riant, F
Marchelli, F
Arnoult, M
Cecillon, M
Maciazek, J
Joutel, A
Tournier-Lasserve, E
机构
[1] Fac Med Lariboisiere, Lariboisiere Med Sch, INSERM E365, F-75010 Paris, France
[2] Assistance Publ Hop Paris, Hop Lariboisiere, Cryogenet Lab, Paris, France
[3] CHU Montpellier Nimes, Dept Neurol, Nimes, France
[4] CHU Tours, Dept Radiol, Tours, France
关键词
D O I
10.1002/ana.10804
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebral Cavernous Malformations (CCM/OMIM 604214) are vascular malformations causing seizures and cerebral hemorrhages. They occur as a sporadic and autosomal dominant condition, the latter being characterized by the presence of multiple CCM lesions. Stereotyped truncating mutations of KRIT1, the sole CCM gene identified so far, have been identified in CCM1 linked families but the clinical features associated with KRIT1 mutations have not yet been assessed in a large series of patients. We conducted a detailed clinical, neuroradiological and molecular analysis of 64 consecutively recruited CCM families segregating a KRIT1 mutation. Those families included 202 KRIT1 mutation carriers. Among the 202 KRIT1 mutation carriers, 126 individuals were symptomatic and 76 symptom-free. Mean age at clinical onset was 29.7 years (range, 2-72); initial clinical manifestations were seizures in 55% of the cases and cerebral hemorrhages in 32%. Average number of lesions on T2 weighted MRI was 4.9 (+/-7.2) and on gradient echo sequences 19.8 (+/-33.2). Twenty-six mutation carriers harbored only one lesion on T2-weighted MRI, including 4 mutation carriers, aged from 18 to 55 yr-old, who presented only one CCM lesion both on T2-weighted and on highly sensitive gradient echo MRI sequences. Five symptom free mutation carriers, aged from 27 to 48 yr-old, did not have any detectable lesion both on T2WI and gradient echo MRI sequences. Within KRIT1/CCM1 families, both clinical and radiological penetrance are incomplete and age dependent. Importantly for genetic counseling, nearly half of the KRIT1 mutation carriers aged 50 or more are symptom-free. The presence of only one lesion, even when using gradient echo MRI sequences, can be observed in some patients with an hereditary form of the disease. Incomplete neuroradiological penetrance precludes the use of cerebral MRI to firmly establish a non carrier status, even at an adult age and even when using highly sensitive gradient echo MRI. Altogether these data suggest that the hereditary nature of the disorder may be overlooked in some mutation carriers presenting as sporadic cases with a unique lesion.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 33 条
[11]  
Labauge P, 1999, ANN NEUROL, V45, P250, DOI 10.1002/1531-8249(199902)45:2<250::AID-ANA17>3.0.CO
[12]  
2-V
[13]   Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas [J].
Laberge-le Couteulx, S ;
Jung, HH ;
Labauge, P ;
Houtteville, JP ;
Lescoat, C ;
Cecillon, M ;
Marechal, E ;
Joutel, A ;
Bach, JF ;
Tournier-Lasserve, E .
NATURE GENETICS, 1999, 23 (02) :189-193
[14]   Germline mutations in the CCM1 gene, encoding krit1, cause cerebral cavernous malformations [J].
Lucas, M ;
Costa, AF ;
Montori, M ;
Solano, F ;
Zayas, MD ;
Izquierdo, G .
ANNALS OF NEUROLOGY, 2001, 49 (04) :529-532
[15]  
MALIK S, 1992, ARCH NEUROL-CHICAGO, V49, P170, DOI 10.1001/archneur.1992.00530260072023
[16]   INTRACRANIAL CAVERNOUS MALFORMATIONS - LESION BEHAVIOR AND MANAGEMENT STRATEGIES [J].
MARAIRE, JN ;
AWAD, IA .
NEUROSURGERY, 1995, 37 (04) :591-605
[17]   Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation test [J].
Marini, V ;
Ferrera, L ;
Dorcaratto, A ;
Viale, G ;
Origone, P ;
Mareni, C ;
Garré, C .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 212 (1-2) :75-78
[18]  
OTTEN P, 1989, NEUROCHIRURGIE, V35, P82
[19]  
OTTEN P, 1989, NEUROCHIRURGIE, V35, P128
[20]  
Perez Lopez-Fraile I, 1995, Neurologia, V10, P242